VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EBMT 2021 | Updates from EMBT 2021: HSCT, CAR-T and COVID-19

Christian Chabannon, MD, PhD, Institut Paoli Calmettes, Marseille, France, outlines the most exciting updates being presented at EBMT 2021, highlighting developments in the field of hematopoietic stem cell transplantation (HSCT), chimeric antigen receptor T-cell (CAR-T) therapy and the impacts of the COVID-19 pandemic on the management of patients receiving transplantation or CAR-T therapy. This interview took place during the 47th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) 2021.

Disclosures

Prof. Christian Chabannon, MD, PhD, has participated in consultancy work or speakers bureaus for Kite/Gilead, Novartis, BMS/Celgene, Janssen, Bellicum Pharmaceuticals, BlueBirdBio, Sanofi SA and Terumo BCT.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter